Beijing Remeet Medical Technology Co., Ltd. held its 20th Board meeting, approving the Q1 2026 report and a share repurchase plan for employee incentives. The meeting was conducted in person and via teleconference, with all directors present. The resolutions will be submitted for shareholder approval.
Summary generated by AI · Always verify with source document
Stock Code: 301367 Stock Abbreviation: Remeet Announcement Number: 2026-028 Beijing Remeet Medical Technology Co., Ltd. Announcement of Resolutions of the 20th Meeting of the Third Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
I. Convening of the Board Meeting
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.